In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Theal tablets Drug Master File in Korea (Theal tablets KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Theal tablets. The MFDS reviews the Theal tablets KDMF as part of the drug registration process and uses the information provided in the Theal tablets KDMF to evaluate the safety and efficacy of the drug.
After submitting a Theal tablets KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Theal tablets API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Theal tablets suppliers with KDMF on PharmaCompass.